Showing results (791-800 of 803) with videos related to

Sort By:
Pageof 81
Assistenza Infermieristica E Ricerca : AIR|February 16, 2005
[A double blind randomised clinical trial to assess the efficacy of the treatments of the superficial pressure sores]Paola Di Giulio, Luisa Saiani, Dario Laquintana, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2023
Clinical standards for the diagnosis and management of asthma in low- and middle-income countriesS Jayasooriya, M Stolbrink, E M Khoo, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Clinical standards for the management of adverse effects during treatment for TBK P Singh, A C C Carvalho, R Centis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
Plos Medicine|September 7, 2012
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsShama D Ahuja, David Ashkin, Monika Avendano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2016
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data MetaanalysisGregory J Fox, Carole D Mitnick, Andrea Benedetti, et al.
BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 81